Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis

Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis

The programmed death-ligand 1 (PD-L1) plays a crucial role in immunomodulatory treatment concepts for end-stage non-small cell lung cancer (NSCLC). To date, its prognostic significance in patients with curative surgical treatment but regional nodal metastases, reflecting tumor spread beyond the prim...

Full description

Bibliographic Details
Main Authors: Florian Eichhorn, Mark Kriegsmann, Laura V. Klotz, Katharina Kriegsmann, Thomas Muley, Christiane Zgorzelski, Petros Christopoulos, Hauke Winter, Martin E. Eichhorn
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
lung cancer
PD-L1
adjuvant therapy
surgery
immunotherapy
NSCLC
Online Access:https://www.mdpi.com/2072-6694/13/9/2046

Internet

https://www.mdpi.com/2072-6694/13/9/2046

Similar Items